Percutaneous Radiofrequency Ablation for Intermediate-Stage Hepatocellular Carcinoma
Authors:
- Kazuya KariyamaKKKazuya Kariyama
- Akiko WakutaAWAkiko Wakuta
- Mamoru NishimuraMNMamoru Nishimura
- Masayuki KishidaMKMasayuki Kishida
- Ayano OonishiAOAyano Oonishi
- Atsushi OhyamaAOAtsushi Ohyama
- Kazuhiro NousoKNKazuhiro Nouso
- Masatoshi KudoMasatoshi Kudo
- 1 November 2015
- journal article
- research article
- Published by S. Karger AG in Oncology
- Vol. 89 (Suppl. 2) , 19-26
Abstract
Objectives: Radiofrequency ablation plays a key role in the treatment of early-stage hepatocellular carcinoma. However, it is not recommended for intermediate-stage hepatocellular carcinoma. The objective of this study was to clarify the efficacy and safety of radiofrequency ablation for treating intermediate-stage hepatocellular carcinoma. Methods: We examined the outcome of 65 consecutive patients who were treated with radiofrequency ablation with or without transarterial chemoembolization for intermediate-stage hepatocellular carcinoma. Results: With a median follow-up of 37 months, overall survival rates of 65 cases at 1, 3, 5, and 7 years were 90, 70, 51, and 36%, respectively. Multivariate analysis of clinical parameters revealed that the multicentric occurrence (MC)/intrahepatic metastasis (IM) was the only significant prognostic factor for overall survival (hazard ratio, 4.9; 95% confidence intervals, 2.1-11.4). Tumor size and tumor number were not significant factors for survival. The overall survival rates of patients with MC (n = 33) at 1, 3, 5, and 7 years were 97, 90, 80, and 59%, respectively; those for patients with IM (n = 32) were 86, 55, 14, and 8%, respectively (p < 0.0001). Two cases (4.9%) had complications of hemothorax and diaphragmatic burn; however, no major complications were observed. Conclusion: Radiofrequency ablation is safe and effective for the treatment of intermediate-stage hepatocellular carcinoma, especially for patients with MC.Keywords
This publication has 54 references indexed in Scilit:
- Liver Transplantation for Hepatocellular CarcinomaLiver Cancer, 2013
- Rescue Living-donor Liver Transplantation for Liver Failure Following Hepatectomy for Hepatocellular CarcinomaLiver Cancer, 2013
- Radiofrequency Ablation Combined with Chemoembolization for Intermediate-Sized (3-5 cm) Hepatocellular Carcinomas Under Dual Guidance of Biplane Fluoroscopy and UltrasonographyKorean Journal of Radiology, 2013
- Epidemiology of Viral Hepatitis and Hepatocellular CarcinomaGastroenterology, 2012
- Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic FactorsAmerican Journal of Gastroenterology, 2012
- Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in JapanCancers, 2012
- Transcatheter Treatment of Hepatocellular Carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): Technical RecommendationsCardioVascular and Interventional Radiology, 2011
- Design and rationale for the non-interventional Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib (GIDEON) studyInternational Journal Of Clinical Practice, 2010
- Radiofrequency ablation of hepatocellular carcinoma: Current statusWorld Journal of Radiology, 2010
- Staging systems in hepatocellular carcinomaHPB, 2005